Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?

J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):101-2. doi: 10.1097/00126334-200201010-00014.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Anti-HIV Agents / pharmacokinetics*
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • HIV Protease Inhibitors / pharmacokinetics*
  • Humans
  • Indinavir / administration & dosage
  • Indinavir / pharmacokinetics*
  • Male
  • Sex Factors

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Indinavir